Self-compassion and pain experience in migraine patients
Abstract
Purpose: The aim of this study was to compare self-compassion levels between migraine patients and healthy controls and to evaluate the relationship of self-compassion with pain perception, migraine-related functional disability, depression and anxiety symptoms. Materials and Methods: This cross-sectional study conducted in Hatay included 68 adults diagnosed with migraine according to ICHD-3 criteria and 58 healthy controls. Self-compassion was measured with Self-Compassion Scale (SCS), pain intensity with Numeric Rating Scale (NRS), depression with Beck Depression Inventory (BDI), anxiety with Beck Anxiety Inventory (BAI), and functional disability with Migraine Disability Assessment Scale (MIDAS). Results: Self-compassion levels were similar between migraine patients (mean 2.65±0.42) and healthy controls (mean 2.64±0.57), with a negligible effect size (Cohen's d=0.023). Depression and anxiety levels were notably elevated in migraine patients: 48.5% of migraine patients were in moderate-to-severe depression categories compared to 25.8% of controls, and no migraine patient reported minimal anxiety whereas 20.7% of controls did. In the migraine group, self-compassion showed a strong negative correlation with depression (r=-0.501) and moderate negative correlation with anxiety (r=-0.295), while these correlations were weaker and non-significant in controls. Self-compassion was highest in the moderate pain group (2.80±0.43), compared to mild (2.41±0.23) and severe (2.52±0.37)…
How strong is the evidence?
Evidence Hub reads this as a cross-sectional, done in people. Its evidence level is 4 of 5 (Low · observational). Observational designs can show an association but not prove cause. Reported size: 68 participants or records.
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.